初次关节置换患者术前贫血的患病率、对结局的影响及治疗效果
本研究回顾2012至2017年一家学术性三级关节置换中心的初次关节置换患者,发现术前贫血患病率为15%;贫血患者输血风险增加4.09倍、住院时间延长19%,而经血液管理项目优化后输血、并发症及再入院风险均降低。
要点
- 初次关节置换患者术前贫血患病率为15%。
- 贫血患者输血风险增加4.09倍,住院时间延长19%。
- 血液管理项目优化可降低输血、并发症及再入院风险。
核心结论
- 该关节置换队列中贫血患病率为15%,术前及时优化贫血可能减少术后贫血相关负担。
研究设计与样本
- 回顾性 review 2012至2017年一家学术性三级关节置换中心所有初次关节置换术,记录术前评估门诊血红蛋白水平,贫血患者考虑进入血液管理项目进一步评估。
- 通过多变量回归分析控制相关协变量,评估术前贫血及血液管理项目治疗对结局的影响。
主要发现
- 17%(932/5384)患者发现贫血,357例参加血液管理项目的患者中115例不再贫血,手术时贫血患者占15%(817/5384)。
- 贫血患者需要输血的可能性是非贫血患者的4.09倍(95% CI:2.64-6.35)。
- 贫血患者发生并发症的可能性是非贫血患者的1.42倍(95% CI:0.99-2.03),住院时间延长19%(95% CI:13%-26%)。
- 参加血液管理项目的患者较未参加的贫血患者输血可能性更低(OR=0.32,95% CI:0.16-0.66)。
- 参加血液管理项目的患者较未参加的贫血患者术后并发症(OR=0.30,95% CI:0.14-0.63)及再入院(OR=0.25,95% CI:0.09-0.71)风险更低。
临床怎么用
- 对初次关节置换患者应术前评估血红蛋白,识别贫血并考虑及时优化。
- 可将贫血患者纳入专门的血液管理项目以降低输血、并发症及再入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aims to: 1) Determine the prevalence of preoperative anemia in arthroplasty; 2) Assess whether preoperative anemia is associated with inferior outcomes; and 3) Ascertain whether optimization in a dedicated blood management program (BMP) is associated with improved outcomes. METHODS: All primary arthroplasties performed at an academic, tertiary-care, arthroplasty center between 2012 and 2017 were reviewed. Hemoglobin level obtained in the preoperative assessment clinic was recorded. Patients with anemia were then considered for further review in BMP. Outcomes included improvement in hemoglobin level post-BMP; length of stay; perioperative transfusion; 90-day readmission, complication, and reoperation rates. The effect of preoperative anemia and the effect of treatment at the BMP on outcomes were evaluated through multivariable regression analysis controlling for relevant covariates. RESULTS: 17% of patients (932/5384) were found to have anemia; 115/357 patients who attended the BMP were no longer anemic. Thus, at time of operation, 15% of patients (817/5384) had anemia. Anemic patients were 4.09 times more likely (95% CI: 2.64-6.35) to require a transfusion; 1.42 times more likely (95% CI: 0.99-2.03) to sustain complications and had 19% longer (95% CI: 13%-26%) length of stay. Those who attended the BMP were less likely to receive a transfusion (OR = 0.32, 95% CI: 0.16-0.66), suffer from postoperative complications (OR = 0.30, 95% CI: 0.14-0.63), or require readmission compared with anemic patients not seen in the BMP (OR = 0.25, 95% CI: 0.09-0.71). CONCLUSIONS: The prevalence of anemia in this arthroplasty cohort was 15%. Preoperative, timely, optimization of anemia should be strongly considered as it is likely to reduce "anemia-associated burden" after arthroplasty.
引用
- Bailey A, Eisen I, Palmer A, et al. Preoperative Anemia in Primary Arthroplasty Patients-Prevalence, Influence on Outcome, and the Effect of Treatment. J Arthroplasty. 2021. PMID: 33549420. doi:10.1016/j.arth.2021.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。